0.345
price up icon0.88%   0.003
after-market After Hours: .31 -0.035 -10.14%
loading
Theriva Biologics Inc stock is traded at $0.345, with a volume of 545.69M. It is up +0.88% in the last 24 hours and down -10.76% over the past month. Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), and acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant recipients; and SYN-020, a recombinant oral formulation for the enzyme intestinal alkaline phosphatase to treat both local GI and systemic diseases. It also develops VCN-01 for the treatment of patients with pancreatic cancer, head and neck squamous cell carcinoma, ovarian carcinoma, colorectal cancer, and retinoblastoma. In addition, the company develops clinical stage products, such as SYN-006 to prevent aGVHD and infection by carbapenem resistant enterococci; SYN-007 for preventing antibiotic associated diarrhea with oral ß-lactam antibiotics; SYN-005 for the prevention and treatment of pertussis; and VCN-11. It has collaborations with The University of Texas at Austin, and Cedars-Sinai Medical Center; and a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. Theriva Biologics, Inc. is headquartered in Rockville, Maryland.
See More
Previous Close:
$0.342
Open:
$0.4349
24h Volume:
545.69M
Relative Volume:
42.12
Market Cap:
$3.31M
Revenue:
-
Net Income/Loss:
$-18.35M
P/E Ratio:
-0.2974
EPS:
-1.16
Net Cash Flow:
$-19.20M
1W Performance:
-18.07%
1M Performance:
-10.76%
6M Performance:
-75.59%
1Y Performance:
-77.00%
1-Day Range:
Value
$0.3416
$0.85
1-Week Range:
Value
$0.283
$0.85
52-Week Range:
Value
$0.283
$2.64

Theriva Biologics Inc Stock (TOVX) Company Profile

Name
Name
Theriva Biologics Inc
Name
Phone
301 417 4364
Name
Address
9605 Medical Center Drive, Suite 270, Rockville
Name
Employee
21
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
TOVX's Discussions on Twitter

Compare TOVX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TOVX
Theriva Biologics Inc
0.345 6.05M 0 -18.35M -19.20M -1.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.39 108.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
463.43 60.82B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.95 61.02B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
817.32 50.01B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.81 34.05B 4.56B -176.77M 225.30M -1.7177

Theriva Biologics Inc Stock (TOVX) Latest News

pulisher
07:55 AM

Why Theriva Biologics Inc. stock could rally in 2025Watch List & Verified Momentum Stock Alerts - newser.com

07:55 AM
pulisher
07:48 AM

Custom watchlist performance reports with Theriva Biologics Inc.Weekly Stock Summary & Free Expert Verified Stock Movement Alerts - newser.com

07:48 AM
pulisher
06:43 AM

How Theriva Biologics Inc. stock reacts to job market dataCPI Data & Proven Capital Preservation Methods - newser.com

06:43 AM
pulisher
06:23 AM

Theriva Biologics reports unusual trading activity, no material changes By Investing.com - Investing.com South Africa

06:23 AM
pulisher
05:41 AM

Theriva Biologics reports unusual trading activity, no material changes - Investing.com

05:41 AM
pulisher
05:29 AM

Can Theriva Biologics Inc. stock rebound after recent weaknessJuly 2025 Fed Impact & Expert Approved Momentum Trade Ideas - newser.com

05:29 AM
pulisher
05:27 AM

What institutional flow reveals about Theriva Biologics Inc.2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com

05:27 AM
pulisher
04:03 AM

Theriva Biologics files prospectus for up to $4 million at-the-market offering - Investing.com

04:03 AM
pulisher
03:35 AM

Theriva Biologics Files Prospectus for Stock Offering - TradingView

03:35 AM
pulisher
03:30 AM

Theriva Biologics (TOVX) Addresses Unusual Stock Activity - GuruFocus

03:30 AM
pulisher
03:04 AM

What technical signals suggest for Theriva Biologics Inc. stockJuly 2025 Outlook & Daily Momentum Trading Reports - newser.com

03:04 AM
pulisher
02:59 AM

Theriva Biologics sees no material development to account for unusual trading - TipRanks

02:59 AM
pulisher
02:38 AM

Theriva Biologics Provides Response to Unusual Market Action - The Manila Times

02:38 AM
pulisher
02:31 AM

Theriva (NYSE American: TOVX) says no undisclosed material updates amid unusual trading - Stock Titan

02:31 AM
pulisher
01:14 AM

Is now a turning point for Theriva Biologics Inc.Exit Point & Safe Entry Trade Signal Reports - newser.com

01:14 AM
pulisher
11:40 AM

Theriva Biologics (TOVX) Stock Surges on Cancer Trial Breakthrough – What’s Next? - ts2.tech

11:40 AM
pulisher
06:23 AM

Can Theriva Biologics Inc. stock expand revenue streamsQuarterly Profit Review & Community Consensus Trade Signals - newser.com

06:23 AM
pulisher
Oct 23, 2025

Pattern recognition hints at Theriva Biologics Inc. upside2025 Price Targets & AI Driven Stock Movement Reports - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Is Theriva Biologics Inc. (SFY0) stock a top pick for value investorsMarket Movement Recap & AI Powered Market Entry Strategies - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

How analysts rate Theriva Biologics Inc. stock today2025 Price Action Summary & Risk Controlled Daily Trade Plans - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Is Theriva Biologics Inc. stock attractive for long term wealth building2025 Biggest Moves & Stock Portfolio Risk Control - newser.com

Oct 23, 2025
pulisher
Oct 22, 2025

Is Theriva Biologics Inc. stock good for long term investingEarnings Beat & High Conviction Buy Zone Picks - newser.com

Oct 22, 2025
pulisher
Oct 22, 2025

What earnings revisions data tells us about Theriva Biologics Inc.July 2025 Breakouts & Weekly High Potential Stock Alerts - newser.com

Oct 22, 2025
pulisher
Oct 21, 2025

How to use Fibonacci retracement on Theriva Biologics Inc.Treasury Yields & AI Powered Trade Plan Recommendations - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Theriva Biologics Inc. stock attractive post correction2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Theriva Biologics Inc. stock chart pattern explained2025 Market Sentiment & Reliable Price Action Trade Plans - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Will breakout in Theriva Biologics Inc. lead to full recovery2025 Market Outlook & Long-Term Safe Return Strategies - newser.com

Oct 20, 2025

Theriva Biologics Inc Stock (TOVX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.26
price up icon 1.11%
$91.28
price up icon 2.21%
$29.89
price up icon 0.07%
$105.66
price up icon 0.87%
$159.66
price down icon 0.29%
biotechnology ONC
$310.81
price up icon 0.25%
Cap:     |  Volume (24h):